Clinical Trial Update: Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating belinostat (PXD101) alone and in combination with 5-fluorouracil in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Belinostat (belinostat)

Snippet

Sponsor: Valerio Therapeutics | Conditions: Tumor | Phase 1 | Status: COMPLETED